Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria
- 1 April 2013
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 41 (4) , 383-387
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002–2010International Journal of Antimicrobial Agents, 2012
- Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?Journal of Antimicrobial Chemotherapy, 2012
- Containment of an Outbreak of KPC-3-Producing Klebsiella pneumoniae in ItalyJournal of Clinical Microbiology, 2011
- Susceptibility of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae According to the New CLSI BreakpointsJournal of Clinical Microbiology, 2011
- Effect of applying the new Clinical and Laboratory Standards Institute ceftazidime and ceftriaxone susceptibility breakpoints for Escherichia coli in Hong KongInternational Journal of Antimicrobial Agents, 2011
- Unreliable Extended-Spectrum β-Lactamase Detection in the Presence of Plasmid-Mediated AmpC in Escherichia coli Clinical IsolatesJournal of Clinical Microbiology, 2009
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concernThe Lancet Infectious Diseases, 2008
- Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coliJournal of Infection, 2007
- Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerationsClinical Microbiology and Infection, 2005
- Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology LaboratoryJournal of Clinical Microbiology, 2001